Cvi Holdings, LLC has filed its 13F form on August 15, 2024 for Q2 2024 where it was disclosed a total value porftolio of $11.5 Million distributed in 144 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Inmune Bio, Inc. with a value of $5.26M, Azz Inc with a value of $3.18M, Regulus Therapeutics Inc. with a value of $717K, Protara Therapeutics, Inc. with a value of $629K, and Bio Line Rx Ltd. with a value of $464K.
Examining the 13F form we can see an decrease of $1.91M in the current position value, from $13.4M to 11.5M .
Cvi Holdings, LLC is based out at Wilmington, DE
Below you can find more details about Cvi Holdings, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$11.5 Million
$7.26 Million
$3.18 Million
$397,000
$352,000
$53,000
$7,000
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q2 2024
New
Keen Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 28.32%
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q2 2024
New
Keen Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 53.92%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 1.59%
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q1 2023
New
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q2 2024
New
Intelligent Bio Solutions In
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 26.24%
Trailblazer Merger Corp I
-
$0
0.0% of portfolio
-
Q2 2023
New
Metal Sky Star Acquisition C
-
$0
0.0% of portfolio
-
Q2 2022
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q4 2023
Reduced 0.95%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 4.2%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 0.02%
-
$0
0.0% of portfolio
-
Q4 2022
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 75.17%
Trailblazer Merger Corp I
-
$0
0.0% of portfolio
-
Q2 2023
New
-
$0
0.0% of portfolio
-
Q1 2021
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 752.74%
Nabors Energy Transition Cor
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 43.0%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.62%
Nova Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 13.23%
-
$0
0.0% of portfolio
-
Q2 2024
New
Oak Woods Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2023
New
Oak Woods Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 12.58%
Oak Woods Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
New
Qomolangma Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.2%
Qomolangma Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2022
New
-
$0
0.0% of portfolio
-
Q3 2023
Reduced 4.19%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 58.53%
Bellevue Life Scncs Aqstn CO
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 83.53%
-
$0
0.0% of portfolio
-
Q2 2024
New
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q3 2023
New
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 2.61%
Bukit Jalil Gbl Acquisition
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
New
Cetus Cap Acquisition Corp
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 23.86%
Cetus Cap Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2023
New
Chenghe Acquisition Ii CO
-
$0
0.0% of portfolio
-
Q2 2024
New
Churchill Capital Corp Ix
-
$0
0.0% of portfolio
-
Q2 2024
New
Conduit Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2023
New
-
$0
0.0% of portfolio
-
Q1 2022
Reduced 1.69%
Bellevue Life Scncs Aqstn CO
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 22.93%
-
$0
0.0% of portfolio
-
Q2 2024
New
